Literature DB >> 34251413

RPS15 mutations rewire RNA translation in chronic lymphocytic leukemia.

Stavroula Ntoufa1, Marina Gerousi1, Stamatia Laidou1, Fotis Psomopoulos1, Georgios Tsiolas1, Theodoros Moysiadis1,2, Nikos Papakonstantinou1, Larry Mansouri3, Achilles Anagnostopoulos4, Niki Stavrogianni4, Sarka Pospisilova5,6, Karla Plevova5,6, Antonios M Makris1, Richard Rosenquist3,7, Kostas Stamatopoulos1,3.   

Abstract

Recent studies of chronic lymphocytic leukemia (CLL) have reported recurrent mutations in the RPS15 gene, which encodes the ribosomal protein S15 (RPS15), a component of the 40S ribosomal subunit. Despite some evidence about the role of mutant RPS15 (mostly obtained from the analysis of cell lines), the precise impact of RPS15 mutations on the translational program in primary CLL cells remains largely unexplored. Here, using RNA sequencing and ribosome profiling, a technique that involves measuring translational efficiency, we sought to obtain global insight into changes in translation induced by RPS15 mutations in CLL cells. To this end, we evaluated primary CLL cells from patients with wild-type or mutant RPS15 as well as MEC1 CLL cells transfected with mutant or wild-type RPS15. Our data indicate that RPS15 mutations rewire the translation program of primary CLL cells by reducing their translational efficiency, an effect not seen in MEC1 cells. In detail, RPS15 mutant primary CLL cells displayed altered translation efficiency of other ribosomal proteins and regulatory elements that affect key cell processes, such as the translational machinery and immune signaling, as well as genes known to be implicated in CLL, hence highlighting a relevant role for RPS15 in the natural history of CLL.
© 2021 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34251413      PMCID: PMC8288675          DOI: 10.1182/bloodadvances.2020001717

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


  15 in total

1.  Distinct gene expression profiling in chronic lymphocytic leukemia with 11q23 deletion.

Authors:  Y Aalto; W El-Rifa; L Vilpo; J Ollila; B Nagy; M Vihinen; J Vilpo; S Knuutila
Journal:  Leukemia       Date:  2001-11       Impact factor: 11.528

2.  Global quantification of mammalian gene expression control.

Authors:  Björn Schwanhäusser; Dorothea Busse; Na Li; Gunnar Dittmar; Johannes Schuchhardt; Jana Wolf; Wei Chen; Matthias Selbach
Journal:  Nature       Date:  2011-05-19       Impact factor: 49.962

3.  Not so lost in translation: RPS15 mutations in CLL.

Authors:  Viktor Ljungström; Richard Rosenquist
Journal:  Blood       Date:  2018-11-29       Impact factor: 22.113

Review 4.  Ribosome profiling: new views of translation, from single codons to genome scale.

Authors:  Nicholas T Ingolia
Journal:  Nat Rev Genet       Date:  2014-01-28       Impact factor: 53.242

5.  Association of chronic lymphocytic leukemia with specific alleles of the HLA-DR4:DR53:DQ8 haplotype in German patients.

Authors:  H K Machulla; L P Müller; A Schaaf; G Kujat; U Schönermarck; J Langner
Journal:  Int J Cancer       Date:  2001-04-15       Impact factor: 7.396

6.  Expression of CD27 and its ligand, CD70, on chronic lymphocytic leukemia B cells.

Authors:  E A Ranheim; M J Cantwell; T J Kipps
Journal:  Blood       Date:  1995-06-15       Impact factor: 22.113

7.  Interleukin-1B (IL1B) and interleukin-6 (IL6) gene polymorphisms are associated with risk of chronic lymphocytic leukaemia.

Authors:  Maria G Ennas; Patrick S Moore; Mariagrazia Zucca; Emanuele Angelucci; Maria G Cabras; Massimo Melis; Attilio Gabbas; Roberto Serpe; Clelia Madeddu; Aldo Scarpa; Pierluigi Cocco
Journal:  Hematol Oncol       Date:  2008-06       Impact factor: 5.271

8.  Genome-wide analysis in vivo of translation with nucleotide resolution using ribosome profiling.

Authors:  Nicholas T Ingolia; Sina Ghaemmaghami; John R S Newman; Jonathan S Weissman
Journal:  Science       Date:  2009-02-12       Impact factor: 47.728

9.  Vascular endothelial growth factor A (VEGFA) gene polymorphisms have an impact on survival in a subgroup of indolent patients with chronic lymphocytic leukemia.

Authors:  Carol Lozano-Santos; Jimena Martinez-Velasquez; Belen Fernandez-Cuevas; Natividad Polo; Belen Navarro; Isabel Millan; Jose Miguel Garcia; Rosa Collado; Pedro Sanchez-Godoy; Felix Carbonell; Jose Antonio Garcia-Vela; Jose Antonio Garcia-Marco; Natalia Gomez-Lozano
Journal:  PLoS One       Date:  2014-06-27       Impact factor: 3.240

10.  Prognostic and predictive role of gene mutations in chronic lymphocytic leukemia: results from the pivotal phase III study COMPLEMENT1.

Authors:  Eugen Tausch; Philipp Beck; Richard F Schlenk; Billy J Jebaraj; Anna Dolnik; Deyan Y Yosifov; Peter Hillmen; Fritz Offner; Ann Janssens; Govind K Babu; Sebastian Grosicki; Jiri Mayer; Panagiotis Panagiotidis; Astrid McKeown; Ira V Gupta; Alexandra Skorupa; Celine Pallaud; Lars Bullinger; Daniel Mertens; Hartmut Döhner; Stephan Stilgenbauer
Journal:  Haematologica       Date:  2020-10-01       Impact factor: 9.941

View more
  2 in total

Review 1.  Ribosome Biogenesis: A Central Player in Cancer Metastasis and Therapeutic Resistance.

Authors:  Amr R Elhamamsy; Brandon J Metge; Heba A Alsheikh; Lalita A Shevde; Rajeev S Samant
Journal:  Cancer Res       Date:  2022-07-05       Impact factor: 13.312

2.  KIF2C affects sperm cell differentiation in patients with Klinefelter syndrome, as revealed by RNA-Seq and scRNA-Seq data.

Authors:  Haihong He; Tingting Huang; Fan Yu; Keyan Chen; Shixing Guo; Lijun Zhang; Xi Tang; Xinhua Yuan; Jiao Liu; Yiwen Zhou
Journal:  FEBS Open Bio       Date:  2022-06-16       Impact factor: 2.792

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.